
FDA warns about rare instances of liver injury, failure with HCV therapies Healio
The FDA has received reports that the use of Mavyret, Zepatier or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver disease has …

FDA warns about rare instances of liver injury, failure with HCV therapies Healio
The FDA has received reports that the use of Mavyret, Zepatier or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver disease has …